Danny Yeung, Prenetics CEO, Unveils ‘The Dual-Engine Revolution’ Manifesto, Offering a Blueprint for Health and Wealth’s Future

This extensive document discloses the strategic vision driving the company’s remarkable expansion and its Bitcoin treasury approach.

IM8, recognized as the fastest-growing supplement brand in its industry’s history, achieved an Annual Recurring Revenue (ARR) of $100 million within just 11 months of its introduction.

IM anticipates revenues between $180 million and $200 million for the fiscal year 2026.

CHARLOTTE, N.C., Oct. 29, 2025 – Prenetics Global Limited (NASDAQ: PRE), referred to as “Prenetics” or “the Company,” a prominent health sciences firm, today released an extensive manifesto. Authored by CEO and Co-Founder Danny Yeung, it is titled “The Dual-Engine Revolution: A Manifesto for Building the Future of Health + Wealth.” This publication offers remarkable insight into the founder-driven Company’s strategic thought process, highlighting the entrepreneurial path and insights that shaped Prenetics’ innovative method of merging rapid healthcare expansion with advanced Bitcoin treasury management.

The manifesto is accessible in various formats to cater to diverse audiences and preferences, featuring a full 32-page document, an executive summary, a video presentation, and an audio narration. It details how combining healthcare growth with Bitcoin treasury management generates substantial, enduring value:

Healthcare Engine (IM8): This brand reached $100 million in annual recurring revenue within 11 months of its introduction, marking the quickest growth ever recorded in the supplement sector. Co-established with David Beckham and supported by World #1 tennis champion Aryna Sabalenka, IM8 forecasts revenues of $180 million to $200 million for 2026.

Bitcoin Treasury Engine: Currently, the Company possesses 277 BTC and systematically increases its holdings by accumulating 1 BTC daily. Prenetics, through this strategy, is constructing what Yeung refers to as a ‘fortress of value,’ offering financial stability and growth prospects distinct from conventional financial markets.

The Synergy: IM8’s rapid expansion produces significant cash flows, facilitating advanced Bitcoin treasury management. Simultaneously, the Bitcoin treasury offers financial appreciation capable of boosting healthcare growth, thus establishing a self-reinforcing cycle unparalleled by businesses relying on a single growth driver.

Access the manifesto in all available formats here:

For detailed financial data and investor resources, please visit:

To view the Company’s Bitcoin holdings in real-time, please visit:

Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com

About Prenetics

Prenetics (NASDAQ: PRE) stands as a prominent health sciences enterprise, reshaping the future of health and longevity via IM8. This flagship consumer brand, co-founded with David Beckham and endorsed by World No. 1 and four-time Grand Slam champion Aryna Sabalenka, is currently the world’s fastest-growing supplement brand. It achieved $100 million in annual recurring revenue within merely 11 months of its introduction, marking the quickest growth ever documented in the global supplements industry, even surpassing today’s leading AI startups.

As the inaugural consumer health company to establish a Bitcoin Treasury, Prenetics maintains its trailblazing position where health innovation meets digital assets, acquiring 1 Bitcoin daily, with its total holdings reaching 277 BTC as of October 29, 2025.

Forward-Looking Statements

This press release includes statements that look to the future. These statements fall under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements are recognizable by terms like “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar phrases. Prenetics may also issue written or verbal forward-looking statements in its regular reports to the U.S. Securities and Exchange Commission, its annual shareholder report, press releases, other written communications, and in verbal communications from its officers, directors, or employees to external parties. Any statements not based on historical facts, including those about Prenetics’ beliefs and projections, are considered forward-looking. These statements carry intrinsic risks and uncertainties. Various factors could lead to actual outcomes differing significantly from what is expressed in any forward-looking statement. These factors include, but are not limited to: the Company’s capacity to fulfill all terms and conditions of its offering and finalize it; the Company’s capability to implement its new Bitcoin treasury strategy; the unpredictable nature of Bitcoin; the Company’s effectiveness in managing its growth and expansion; the company’s competitiveness in the intensely competitive consumer health sector; and other inherent risks and uncertainties. Additional details concerning these and other risks are available in Prenetics’ filings with the U.S. Securities and Exchange Commission. All information presented in this press release is current as of its publication date, and Prenetics is not obligated to update any forward-looking statement unless mandated by applicable law.